Drug approvals

June 29, 2018 - 10:55 am
The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety. Dermira Inc. said Friday its Qbrexza (cue-BREX'-zah) was approved for excessive underarm sweating. The drug is inside a cloth wiped over...
Read More
June 25, 2018 - 12:51 pm
WASHINGTON (AP) — U.S. health regulators have approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law. The Food and Drug Administration approved the medication from GW Pharmaceuticals on Monday to treat...
Read More
In this Monday, April 23, 2018, photo, Lukas Inman, 19, interacts with his father in Colorado Springs, Colo. Inman suffers from a rare and severe form of epilepsy called Lennox-Gastaut Syndrome. A British pharmaceutical company is getting closer to a decision on whether the U.S government will approve the first prescription drug derived from the marijuana plant, but parents, including Lukas,' who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory. (AP Photo/Thomas Peipert)
June 19, 2018 - 2:11 pm
COLORADO SPRINGS, Colo. (AP) — Some American parents who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory as U.S. regulators near a decision on whether to approve the first drug derived from the marijuana plant. The U.S...
Read More
June 04, 2018 - 2:42 am
BERLIN (AP) — German pharmaceutical company Bayer AG says it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on Thursday. The deal...
Read More

Pages